跳至主要内容
临床试验/CTRI/2021/10/037194
CTRI/2021/10/037194已完成未知

Assessment of prevalence of dyspnoea in advanced cancer and its impact on quality of life: a prospective randomised study

Tata Memorial Hospital0 个研究点目标入组 498 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
498

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. All patients with advanced cancer (stage IV diagnosis), referred for the first time to Department of Palliative Medicine
  • 2. Age more than 18 years
  • 3. Patient with normal cognitive status as determined by the physician and by her/his ability to understand the nature of the study and provide consent for the process
  • 4. Patient willing to participate in the study and sign informed consent

排除标准

  • 1. Patients unable to give consent due to impaired cognition, moribund state and acute medical illness
  • 2. Those who refuse to participate in the study

研究者

相似试验